To determine the effect of degenerative disease of the lumbar spine on bone mineral density in the lumbar spine and femoral neck.
The use of dual energy x-ray absorptiometry (DXA) for the diagnosis of osteoporosis is now standard in most clinical settings. Measurement of bone mineral density (BMD) with DXA allows the diagnosis of osteoporosis, the estimation of risk of fracture, and the monitoring of response to therapy. BMD is usually measured at the lumbar spine and proximal femur because these sites are affected early in the course of osteoporosis and are the most common sites of osteoporotic fractures. A common pitfall of DXA scan interpretation in elderly patients is the elevation of spine BMD measurements owing to the presence of spinal degenerative disease, a phenomenon demonstrated previous studies (1 4) . Furthermore, reports of several studies have reported that spinal degenerative disease results in elevated BMD measurements not only locally in the spine, but generally throughout the skeleton (5 7). If degenerative disease is indeed a generalized disorder affecting the entire skeleton, the ramifications of this will be important in the diagnosis of osteoporosis. For example, patients with spinal degenerative disease would be expected to have elevated BMD in the hip, and this, in turn might offer protection from osteoporotic fracture. Some studies, however, have reported no apparent association between degenerative disease and BMD (8 13) . The purpose of this study was to evaluate the effect of degenerative disease of the lumbar spine, as diagnosed with radiographs, on BMD in the lumbar spine and femoral neck, as measured with DXA.
Materials and Methods
We retrospectively evaluated radiographs and DXA scans of the lumbar spine and hip in 305 Caucasian women with suspected osteoporosis. The following subjects were excluded from the study: those younger than 40 years of age (n = 18), those with osteoarthritis of the hip (n = 27), scoliosis (n = 11), fractures of the lumbar spine (n = 36), lumbar spinal instrumentation (n = 5), arthroplasty of the hip (n = 2), metabolic bone disease other than osteoporosis (n=8), and those treated with medications, including corticosteroids, known to influence bone metabolism (n=12). In the remaining 186 women, anteroposterior (AP) and lateral radiographs of the lumbar spine were independently evaluated for the presence of degenerative disease by two musculoskeletal radiologists unaware of the results of DXA scans.
The radiographic criteria for degenerative disease included disc space narrowing, subchondral sclerosis of the vertebral endplates, osteophytes, and facet joint osteoarthritis (14) . In each patient, the severity of degenerative disease from the L1-L2 level to the L4-L5 level was categorized as absent/mild (Fig. 1A) or moderate/severe ( Fig. 2A) . Those with absent/mild degenerative disease were assigned to the control group and those with moderate/severe degenerative disease to the degenerative group. Discrepant interpretations were discussed by the two radiologists, who then reached a consensus. In each patient, BMD of the lumbar spine and femoral neck was measured using a Lunar DPX densitometer (Lunar Corporation, Madison, Wis., U.S.A.). Lumbar spine and femoral neck scans were obtained with the patient in the supine position. Lumbar spine measurement was analyzed from the L2 to the L4 vertebra, and BMD values were expressed as area density (g/cm 2 ). BMD measurements of the lumbar spine and femoral neck in the degenerative group were compared with those in the control group; by means of analysis of variance (ANOVA), measurements were adjusted for the patient s age, weight and height. For all data management and statistical computations, JMP statistics software (SAS Institute, Cary, N.C.) was used.
Results
With regard to the presence of degenerative disease, interobserver agreement was good (kappa = 0.81). Forty-five (24%) of 186 women were included in the degenerative group, and 141 (76%) in the control group. Table 1 compares the mean age, height and weight of women in the degenerative and control group.
In the former group (Fig. 2) , the mean BMD measurement was 1.075 g/cm 2 in the spine and 0.788 g/cm 2 in the femoral neck (Table 2) , while in the control group ( Fig. 1) , the corresponding measurements were 0.989 g/cm 2 and 0.765 g/cm 2 . After adjusting for each patient s age, weight and height by means of ANOVA, degenerative disease of the lumbar spine was found to be a significant predictor of increased spinal BMD (p = 0.0001). Furthermore, in patients whose hip radiographs were normal, degenerative disease of the spine was a significant predictor of increased BMD in the femoral neck (p = 0.0287).
Discussion
Our results in 186 postmenopausal women indicate that those with radiographic findings of moderate to severe spinal degenerative disease had significantly higher BMD in the spine than did women whose radiographic findings were consistent with absent or mild degenerative disease. The results were significant even after the two groups were adjusted for age, weight and height (Tables) A. Lateral spine radiograph in a 50-year-old woman shows preservation of disk spaces, minimal osteophytes, and minimal facet osteoarthritis. Based on these radiographic findings, the patient was placed into control group. B. Dual energy x-ray absorptiometry scan of lumbar spine. BMD as measured from L2 to L4 is 106% of young-adult reference (T-score is 0.62.) (arrowhead). C. Dual energy x-ray absorptiometry scan of left hip. BMD as measured in femoral neck is 77% of young-adult reference (T-score is 1.92.) (arrowhead). A. Lateral spine radiograph in a 56-year-old woman shows extensive disk space narrowing, subchondral sclerosis, and osteophytes at L3-L4 and L4-L5 levels. Based on these radiographic findings, the patient was placed into degenerative disease group. B. Dual energy x-ray absorptiometry scan of lumbar spine. BMD as measured from L2 to L4 is 124% of young-adult reference (Tscore is 2.35.) (arrowhead). C. Dual energy x-ray absorptiometry scan of left hip. BMD as measured in femoral neck is 99% of young-adult reference (T-score is 0.07.) (arrowhead). D. Frontal radiograph of left hip shows no radiographic evidence for hip osteoarthritis. and apophyseal disease were associated with elevated spinal BMD. In most studies, the increase in spinal BMD in patients with spinal degenerative disease was attributed to the presence of osteophytes, to narrowing of the intervertebral joint space, or to sclerosis of the facet joint (4, 6, 7, 15, 16) . Because lumbar osteophytes, subchondral sclerosis and facet osteoarthritis result in a relative increase in cortical bone, elevated spinal BMD in patients with these findings was expected.
The fact that BMD measurements are elevated in the presence of local degenerative disease is further supported by studies of anatomic regions other than the lumbar spine. In a population-based study of men and women aged 55 years or more, Burger et al. (17) reported that the grade of hip osteoarthritis, as determined radiographically, showed a significant correlation with femoral neck BMD, as measured with DXA.
Considerably more significant than the finding of elevated spinal BMD in the degenerative group was our finding that women with radiographic findings of moderate to severe spinal degenerative disease had elevated BMD in the femoral neck, despite normal radiographs of the hip (Fig. 2) . Our findings support those of prior studies in which elevated BMD measurements were reported at sites shown by radiographs to be unaffected by degenerative disease (5, 7, 18) . Hart et al. (18) reported that BMD was significantly higher in patients with degenerative disease of the lumbar spine than in controls, not only in the lumbar spine (+7.8%) but also in the femoral neck (+6.3%). Similarly, Jones et al. (7) reported increased BMD in the femoral neck in women with spinal degenerative disease. Peel et al. (5) recently reported that patients with spinal degenerative disease showed increased BMD in the lumbar spine, femoral neck, and total body, and suggested that the results may reflect a generalized increase in BMD or may be due to degenerative changes such as osteophytes in regions other than the spine. In our study, patients with radiographic evidence of hip degenerative disease were excluded, and a generalized elevation of BMD is thus the more likely explanation.
Further supporting the argument that spinal degenerative disease results in a generalized increase in BMD is the fact that the presence of osteophytes in the region of the hip should not affect BMD in the femoral neck. In the spine, elevated BMD is often considered a consequence of facet sclerosis and osteophytes, but the femoral neck measurement is removed from osteophytes and subchondral sclerosis and BMD at that site should not be elevated, even in patients with radiographically apparent degenerative disease of the hip (5). In our study, women with radiographic evidence of hip osteoarthritis were excluded, and increased BMD in the femoral neck is thus not due to degenerative disease of the hip. Our results and those of prior investigators suggest an intrinsic increase in femoral neck BMD in women with spinal degenerative disease and the presence of spinal degenerative disease might thus be an indicator of decreased risk for osteoporotic hip fractures. This is important in that BMD is considered the major determinant of osteoporotic fracture risk and osteoporotic fracture mortality is associated primarily with hip fractures (19) .
The theory that degenerative disease results in a generalized increase in BMD is also supported by studies in which radiographic findings of degenerative disease were correlated with BMD measurements at other anatomic sites. Nevitt et al. (20) reported that elderly Caucasian women with moderate to severe osteoarthritis of the hip, as determined radiographically, had higher BMD in the spine and appendicular skeleton. Similarly, Gotfredsen et al. (21) reported that patients with osteoarthritis of the hip had higher bone mineral content, as measured in the total body. Hannan et al. (22) reported that femoral BMD was higher in women with degenerative disease of the knee, and even degenerative disease of the hand has been associated with elevated axial BMD (18, 23) . Hart et al. (18) reported that degenerative disease of the distal interphalangeal joints was associated with increased lumbar spine BMD, and degenerative disease of the first carpometacarpal joint was associated with higher spine and femoral neck BMD, after adjustment for age, obesity, and vertebral osteophytes.
Some studies, however, have failed to demonstrate an association between degenerative disease and BMD (1, 8) . Hochberg et al. (9) , in a study of degenerative disease of the hand (Kellgren-Lawrence grade), found no significant association between metacarpal bone mass (percent cortical area of the second metacarpal) and distal radius BMD ( determined by single-photon absorptiometry). Other investigators (10 12) reported no increase in BMD of the distal radius or total body in patients with generalized osteoarthritis involving the hand. These conflicting reports may be attributable to differences in the selection of patients and controls, the selection of measurement sites, and the expression of results (13) .
Our results are in line with those of prior studies indi-cating an inverse relationship between osteoporosis and osteoarthritis, one that has important ramifications for the evaluation of patients in whom osteoporosis is suspected. Generalized degenerative disease in women usually manifests at the time of the menopause, before major bone loss occurs; its presence may therefore be a good negative predictor of osteoporosis (13) . Because BMD is considered the major determinant of fracture risk (19) , patients with elevated BMD owing to the presence of degenerative disease may be protected from osteoporotic fractures.
In conclusion, in our study of 186 women over 40 years of age, spinal BMD was significantly higher in those with radiologic evidence of degenerative disease of the lumbar spine. More importantly, femoral neck BMD was also significantly higher in patients with spinal degenerative disease and with no radiographic evidence of osteoarthritis of the hip. Our findings suggest that degenerative disease of the lumbar spine, which leads to an intrinsic increase in BMD in the femoral neck, may thus be a good negative predictor of osteoporotic hip fractures. Whether elevated BMD in patients with osteoporosis offers protection from osteoporotic fracture remains to be determined.
